ARCHITECT C-PEPTIDE REAGENT
Report
- Report Number
- 1415939-2011-00532
- Event Type
- Malfunction
- Date Received
- August 6, 2011
- Report Date
- June 30, 2011
- Manufacturer
- ABBOTT LABORATORIES
- Product Code
- JKD
- PMA / PMN Number
- EXEMPT
- Removal / Correction Number
- 1415939-7/11/11-001-R
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- JA
- Reporter Occupation
- OTHER
Narratives
(B)(4): HIGH TEST RESULTS. THE CAUSE OF THE ARCHITECT C-PEPTIDE FALSELY ELEVATED QUALITY CONTROLS AND PATIENT RESULTS WAS DUE TO A NEW ANTIBODY LOT USED IN THE MANUFACTURING OF THE C-PEPTIDE MICROPARTICLE AND/OR CONJUGATE REAGENTS. ABBOTT ISSUED A PRODUCT RECALL LETTER TO ALL CUSTOMERS WITH INSTRUCTIONS TO DISCARD AND DESTROY ANY REMAINING INVENTORY OF THE AFFECTED LOTS.
THE CUSTOMER OBSERVED A FALSELY ELEVATED ARCHITECT C-PEPTIDE PATIENT RESULT WHEN REAGENT LOT 00110L000 WAS IN USE. THE CUSTOMER WAS PERFORMING A CORRELATION BETWEEN THE LUMIPULSE F METHOD AND THE ARCHITECT C-PEPTIDE ASSAY AND OBSERVED THE DISCREPANT RESULT FOR A TYPE 1 DIABETIC PATIENT SAMPLE. ANOTHER SAMPLE FROM THE SAME PATIENT WAS TESTED AND A REPEAT ELEVATED RESULT WAS GENERATED EVEN AFTER CENTRIFUGATION OF THE SAMPLE. THE CUSTOMER ALSO TESTED ALIQUOT SAMPLES FROM THE SAME PATIENT WHICH WERE COLLECTED BEFORE AND AFTER A MEAL. THE CUSTOMER ALSO OBSERVED POOR DILUTION LINEARITY WITH THE SUSPECT SAMPLE, THEREFORE, THE CUSTOMER DECIDED THERE WAS A HIGH POSSIBILITY OF NON SPECIFIC REACTION OF THE DIABETIC PATIENT SAMPLE WITH THE ARCHITECT C-PEPTIDE ASSAY. THERE WAS NO IMPACT TO PATIENT MANAGEMENT.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1 | ARCHITECT C-PEPTIDE REAGENT | JKD | ABBOTT LABORATORIES | 00110L000 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | LUMIPULSE F C-PEPTIDE ASSAY| ARCHITECT I1000SR ANALYZER, LIST # 1L86-01 |